Aposense

  • Home
  • About Us
    • Our mission and vision
    • Scientific president
    • Team
    • Board of directors
    • Scientific advisory board
    • Intellectual property
  • Our Technology
  • Our Platform
  • Investors
    • Presentations
    • Financial Reports
    • Stock Information
  • News Room
    • Press release
    • Publications
  • Other Projects
    • ATT-11T: Anti cancer pro-drug
    • ML-10
  • Contact Us


Successful completion of the POC program in the Apo-Si technology

Posted on July 11, 2017 by

Successful completion of the POC program in the Apo-Si technology

Download

Posted in press release
Aposense

Contact Us

Telephone: + 972.73.239.7600
Fax: +972.3.921.57.14
E-mail: info@aposense.com

Careers

Latest news

  • EVENT: BIO INVESTOR Forum, October 17-18, San Francisco, California

    24 Sep 2017

  • EVENT: BIO-Europe, Berlin Germany 6-8 November

    14 Sep 2017

  • Convening of a Shareholders Meeting – August 2017

    13 Jul 2017

Aposense © 2018. Privacy Policy
  • Home
  • About Us
    ▼
    • Our mission and vision
    • Scientific president
    • Team
    • Board of directors
    • Scientific advisory board
    • Intellectual property
  • Our Technology
  • Our Platform
  • Investors
    ▼
    • Presentations
    • Financial Reports
    • Stock Information
  • News Room
    ▼
    • Press release
    • Publications
  • Other Projects
    ▼
    • ATT-11T: Anti cancer pro-drug
    • ML-10
  • Contact Us